GA
CLX icon

Geneva Advisors’s Clorox CLX Stock Holding History

Geneva Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$304K Sell
2,281
-147
-6% -$19.8K 0.01% 604
2017
Q1 		$327K Buy
2,428
+148
+6% +$19.2K 0.01% 579
2016
Q4 		$274K Sell
2,280
-24
-1% -$2.83K 0.01% 608
2016
Q3 		$288K Buy
2,304
+1
+0% +$131 0.01% 587
2016
Q2 		$319K Buy
2,303
+1
+0% +$130 0.01% 540
2016
Q1 		$290K Sell
2,302
-8
-0.3% -$1.02K 0.01% 545
2015
Q4 		$293K Hold
2,310
– – 0.01% 507
2015
Q3 		$267K Sell
2,310
-27
-1% -$3.03K 0.01% 509
2015
Q2 		$243K Sell
2,337
-14
-0.6% -$1.51K ﹤0.01% 561
2015
Q1 		$260K Buy
2,351
+153
+7% +$16.6K ﹤0.01% 546
2014
Q4 		$229K Buy
2,198
+1
+0% +$100 ﹤0.01% 575
2014
Q3 		$211K Buy
2,197
+1
+0% +$90 ﹤0.01% 583
2014
Q2 		$201K Buy
+2,196
New +$197K ﹤0.01% 597

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VAM
ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geneva Advisors's CLX Position: Q2 2017 in Review

Geneva Advisors reduced its Clorox (CLX) stake by 6.1% in Q2 2017, selling an estimated $19.8K and leaving 2,281 shares worth $304K. The position accounts for 0.01% of the portfolio, ranked #604.

Geneva Advisors first reported a position in CLX in Q2 2014 and has held it in 13 quarters since. The position peaked at $327K in Q1 2017. 866 funds tracked by Wall St. Rank hold CLX as of Q2 2017.

  • Geneva Advisors held 2,281 shares of Clorox worth $304K as of Q2 2017.
  • Geneva Advisors sold 147 Clorox shares in Q2 2017, an estimated $19.8K.
  • Clorox made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #604 holding.
  • Geneva Advisors first reported a position in Clorox in Q2 2014 and has held it in 13 quarters since.
  • Geneva Advisors's Clorox position peaked at $327K in Q1 2017.
  • 866 funds tracked by Wall St. Rank held Clorox as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.